The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients

Clinical trial NCT05102773 · COMPLETED

Trial details

NCT number: NCT05102773
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Clinical Stage IV Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8

Start date: 2020-02-10
Primary completion: 2022-05-05
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.